Neuropeptide Y Selectively Potentiates α 1-Adrenoceptor-Mediated Contraction Through Y1 Receptor Subtype in Rat Femoral Artery

Journal of Cardiovascular Pharmacology

Volumn 42, Issue SUPPL. 1, 2003, Pages

  Tsurumaki, Tatsuru ^a   Honglan, Piao ^a   Higuchi, Hiroshi ^a  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

Author keywords

Neuropeptide Y; Synergism; Y1 receptor; 1 adrenoceptor

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; MESSENGER RNA; NALPHA (DIPHENYLACETYL) N (4 HYDROXYBENZYL) DEXTRO ARGININAMIDE; NEUROPEPTIDE Y; NEUROPEPTIDE Y RECEPTOR ANTAGONIST; NEUROPEPTIDE Y1 RECEPTOR; PHENYLEPHRINE; SEROTONIN;

ANIMAL CELL; ANIMAL TISSUE; ARTERY CONSTRICTION; CONFERENCE PAPER; CONTROLLED STUDY; DOSE RESPONSE; DRUG POTENTIATION; FEMORAL ARTERY; MALE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THORACIC AORTA;

EID: 0344586189     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200312001-00009     Document Type: Conference Paper

References (24)

1. Tatemoto K, Carlquist M, Mutt V. Neuropeptide Y-a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide. Nature 1982:296:659-60.
2. Tatemoto K. Neuropeptide Y: complete amino acid sequence of the brain peptide. Proc Natl Acad Sci USA 1982;79:5485-9.
3. Higuchi H, Yang HY, Sabol S. Rat Neuropeptide Y precursor gene expression - mRNA structure, tissue distribution, and regulation by glucocorticoids, cyclic AMP, and phorbol ester. J Biol Chem 1988;263:6288-95.
4. Ekblad E, Edvinsson L, Wahlestedt C, et al. Neuropeptide Y coexists and co-operates with noradrenaline in perivascular nerve fibers. Regul Pept 1984;8:225-35.
5. Edvinsson L, Håkanson R, Wahlestedt C, et al. Effects of neuropeptide Y on the cardiovascular system. Trends Pharmacol Sci 1987;8:231-5.
6. Smyth L, Bobalova J, Ward SM, et al. Neuropeptide Y is a cotransmitter with norepinephrine in guinea pig inferior mesenteric vein. Peptides 2000;21:835-43.
7. Myers AK, Farhat MY, Vaz CA, et al. Release of immunoreactiveneuropeptide Y by rat platelets. Biochem Biophys Res Commun 1988;155:118-22.
8. Hassall CJS, Burnstock G. Immunocytochemical localization of neuropeptide Y and 5-hydroxytryptamine in a subpopulation of amine-handling intracardiac neurones that do not contain dopamine-β-hydroxylase in tissue culture. Brain Res 1987;422:74-82.
9. Cortés V, Donoso VM, Brown N, et al. Synergism between neuropeptide Y and norepinephrine highlights sympathetic cotransmission: studies in rat arterial mesenteric bed with neuropeptide Y, analogs, and BIBP 3226. J Pharmacol Exp Ther 1999;289:1313-22.
10. Tsurumaki T, Muraoka O, Yamaguchi T, et al. Neuropeptide Y-induced contraction and its desensitization through the neuropeptide Y receptor subtype in several rat veins. J Cardiovasc Pharmacol 2003;41(Suppl. 1):S23-S27.
11. Weinberg DH, Sirinathsinghji DJS, Tan CP, et al. Cloning and expression of a novel neuropeptide Y receptor. J Biol Chem 1996;271:16435-8.
12. Larhammar D. Structural diversity of receptors for neuropeptide Y, peptide YY and pancreatic polypeptide. Regul Pept 1996;65:165-74.
13. Naveilhan P, Neveu I, Arenas E, et al. Complementary and overlapping expression of Y1, Y2 and Y5 receptors in the developing and adult mouse nervous system. Neuroscience 1998;87:289-302.
14. Modin A, Pernow J, Lundberg, JM. Evidence for two neuropeptide Y receptors mediating vasoconstriction. Eur J Pharmacol 1991;203:165-71.
15. 2 receptor of neuropeptide Y. Eur J Pharmacol 1997;327:163-7.
16. Newhouse MJ, Hill CE. A role for neuropeptide Y in rat iridial arterioles. Am J Physiol Heart Circ Physiol 1997;273:H2119-H2127.
17. Han S, Yang CL, Chen X, et al. Direct evidence for the role of neuropeptide Y in sympathetic nerve stimulation-induced vasoconstriction. Am J Physiol Heart Circ Physiol 1998;274:H290-H294.
18. Michel MC, Beck-Sickinger A, Cox H, et al. International union of pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptor. Pharmacol Rev 1998;50:143-50.
19. Franco-Cereceda A, Liska J. Neuropeptide Y receptors in vascular pharmacology. Eur J Pharmacol 1998;349:1-14.
20. Wahlestedt C, Edvinsson L, Ekblad E, et al. Neuropeptide Y potentiates noradrenaline-evoked vasoconstriction: mode of action. J Pharmacol Exp Ther 1985;234:735-41.
21. 1-adrenoceptors on vascular smooth muscle: correlation with the regulation of contraction. J Pharmacol Exp Ther 1999;290:452-63.
22. Piascik MT, Hrometz SL, Edelmann SE, et al. Immunocytochemical localization of the alpha-1B adrenergic receptor and the contribution of this and other subtypes to vascular smooth muscle contraction: analysis with selective ligands and antisense oligonucleotides. J Pharmacol Exp Ther 1997;283:854-68.
23. 1-adrenoceptor antagonists in rat aorta. Br J Pharmacol 1996;118:299-310.
24. Guimaraes S, Moura D. Vascular adrenoceptors: an update. Pharmacol Rev 2001;53:319-56.